Patents by Inventor Xueyuan Cao

Xueyuan Cao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PREDICTING AML OUTCOME
    Publication number: 20230073558
    Abstract: Aspects of the disclosure relate to compositions and methods for predicting prognosis and classifying risk of subjects having certain cancers, for example acute myeloid leukemia (AML). In some embodiments, methods described by the disclosure comprise a step of assessing the mRNA expression of certain leukemic stem cell (LSC)-enriched genes in a subject to produce a predictive score for pediatric AML. In some embodiments, methods described by the disclosure comprise a step of assessing the mRNA expression of certain genes of pharmacological relevance for standard chemotherapy consisting of Cytarabine (also known as Ara-C), daunorubicin and etoposide in a subject to produce a predictive score for pediatric AML.
    Type: Application
    Filed: September 22, 2020
    Publication date: March 9, 2023
    Applicants: University of Florida Research Foundation, Incorporated, St. Jude Children's Research Hospital, Inc., University of Tennessee Research Foundation
    Inventors: Jatinder Kaur Lamba, Stanley Pounds, Abdelrahman H. Elsayed, Xueyuan Cao